Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Lei Huang
Period: Reporting periods mapped to calendar 2025 Q2 – 2025 Q4 (3 quarters).
- Questions
- 5on tracked calls
- Challenge rate
- 0%none of 5 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 3with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 5 of 5 questions from 1 company
SOLVSolventum5 questions · 3 reporting periods · 0 of 5 challenging
Calendar 2025 Q4
Last year, when you had the European one, there was some pull forward buying in the first half. Is that something you should consider for 2026
Show response
CFO noted several ERP waves planned for 2026 with goal to finish by year-end; difficult to predict volume timing; will call out any material impacts in actuals.
Anything we should think about as far as pricing for '26 either for the overall company or across segments
Show response
CFO confirmed normalized ±1% pricing expected again in 2026; focus remains entirely on sustainable volume growth rather than pricing as growth driver.
Calendar 2025 Q3
Can you share any color as far as how to think about margin expansion kind of like that's also ahead of plan
Show response
CFO confirmed margin expansion planned in 2026 despite annualizing tariffs; Transform for Future and programmatic savings designed to offset. CEO explicitly took concern off table that tariffs would drive margins down.
Can you just remind us what you said about potential areas of interest. And any comment on how soon you might expect to see something
Show response
CEO confirmed actively looking for sub-$1B tuck-ins in existing markets to reduce risk; MedSurg is area of concentration given scale, but looking across all businesses.
Calendar 2025 Q2
how should we think about quarterly cadence for growth in the second half in general? And any additional comments around growth outlook for the other segments
Show response
CEO indicated Q3 pressure from order timing reversal with improvement into Q4; CFO confirmed without providing specific quarterly growth rates.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| SOLV Solventum | 5 | 0%none of 5 questions |
- SOLVSolventum · 5 questions0%none of 5 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | 2 | 0%none of 2 questions | 1 |
| 2025 Q4 | 2 | 0%none of 2 questions | 1 |
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Revenue Growth2
- Supply Chain1
- Pricing1
- Margin1
- Trade Tariffs1
- M&A1